Preventing Lung Scarring May Extend Lives Of Lung Cancer Patients
Wednesday, October 31st, 2007
Researchers have found that using a special type of drug called a pharmaceutical monoclonal antibody to block the integrin beta6-TGF-beta pathway prevents a serious side effect of radiation therapy for lung cancer patients — pulmonary fibrosis — thereby extending patients’ lives and improving their quality of life, according to a new study.
- Article Source
- Article Source
